An Open-Label, Randomized, Multicenter, Two-Arms Efficacy and Safety Study of 14 Days Treatment With Finafloxacin 400 mg b.i.d. Plus Amoxicillin 1000 mg b.i.d.Versus Finafloxacin 400 mg b.i.d. Plus Esomeprazole 40 mg b.i.d. in Patients With Helicobacter Pylori Infection.

Trial Profile

An Open-Label, Randomized, Multicenter, Two-Arms Efficacy and Safety Study of 14 Days Treatment With Finafloxacin 400 mg b.i.d. Plus Amoxicillin 1000 mg b.i.d.Versus Finafloxacin 400 mg b.i.d. Plus Esomeprazole 40 mg b.i.d. in Patients With Helicobacter Pylori Infection.

Completed
Phase of Trial: Phase II

Latest Information Update: 23 Feb 2012

At a glance

  • Drugs Amoxicillin; Esomeprazole; Finafloxacin
  • Indications Dyspepsia; Helicobacter pylori infections
  • Focus Therapeutic Use
  • Acronyms FLASH
  • Most Recent Events

    • 23 Feb 2012 Last checked against European Clinical Trials Database.
    • 17 Jun 2009 Actual end date (Apr 2009) added as reported by ClinicalTrials.gov.
    • 17 Jun 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top